These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 169373)

  • 1. Inhibitory effect of adult bovine serum on release of infectious Epstein-Barr virus from a virus-carrier cell line.
    Sairenji T; Hinuma Y
    J Natl Cancer Inst; 1975 Aug; 55(2):339-43. PubMed ID: 169373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
    J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1.
    Nagoya T; Hinuma Y
    Gan; 1972 Feb; 63(1):87-93. PubMed ID: 4339714
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
    Margalith M; Manor D; Cohen T
    Cancer Biochem Biophys; 1983; 6(3):189-96. PubMed ID: 6303555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
    Sairenji T; Hinuma Y
    Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
    Ito Y; Kishishita M; Yanase S
    Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of production of Epstein-Barr virus in P3HR-1 cell line by bovine serum.
    Hinuma Y; Sairenji T
    Bibl Haematol; 1975; (40):589-91. PubMed ID: 169827
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epstein-Barr virus (EBV): evidence for EBV strains.
    Menezes J; Leibold W; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):323-30. PubMed ID: 190135
    [No Abstract]   [Full Text] [Related]  

  • 14. Search for infectious Epstein-Barr virus-releasing cell lines, with particular reference to a new producer line, NHAd-60.
    Sakamoto K
    Gan; 1977 Apr; 68(2):145-50. PubMed ID: 196968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Epstein-Barr virus-negative Burkitt lymphoma cell line (sfRamos) secretes a prolactin-like protein during continuous growth in serum-free medium.
    Baglia LA; Cruz D; Shaw JE
    Endocrinology; 1991 May; 128(5):2266-72. PubMed ID: 1850347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of 1-beta-D-arabinofuranosylthymine on synthesis of Epstein-Barr virus.
    Yonemura K; Sairenji T; Hinuma Y
    Microbiol Immunol; 1981; 25(6):557-63. PubMed ID: 6268944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale production and concentration of infectious Epstein-Barr virus.
    Klein F; Rosensteel JF; Hummer RM; Hillman EA; Riggs CW; Charmella LJ
    Appl Environ Microbiol; 1978 Jan; 35(1):172-8. PubMed ID: 203227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between amount of Epstein-Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cell.
    Ernberg I; Andersson-Anvret M; Klein G; Lundin L; Killanger D
    Nature; 1977 Mar; 266(5599):269-71. PubMed ID: 191759
    [No Abstract]   [Full Text] [Related]  

  • 20. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
    Dölken G; Gier A; Finke J; Weitzmann U
    Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.